News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
139,558 Results
Type
Article (11082)
Company Profile (58)
Press Release (128418)
Section
Business (40938)
Career Advice (113)
Deals (7228)
Drug Delivery (9)
Drug Development (19339)
Employer Resources (14)
FDA (3345)
Job Trends (2809)
News (70944)
Policy (6414)
Tag
Academia (712)
Alliances (14109)
Alzheimer's disease (338)
Approvals (3328)
Artificial intelligence (25)
Best Places to Work (2482)
Biotechnology (56)
Breast cancer (36)
Cancer (298)
Cardiovascular disease (23)
Career advice (101)
CAR-T (23)
Cell therapy (83)
Clinical research (15153)
Collaboration (147)
Compensation (38)
COVID-19 (522)
C-suite (23)
Cystic fibrosis (49)
Data (393)
Diabetes (25)
Diagnostics (1918)
Drug discovery (26)
Duchenne muscular dystrophy (23)
Earnings (13314)
Events (17644)
Executive appointments (69)
FDA (3499)
Funding (80)
Gene editing (44)
Gene therapy (109)
GLP-1 (91)
Government (675)
Healthcare (3191)
Infectious disease (539)
Inflammatory bowel disease (32)
IPO (2985)
Job creations (489)
Job search strategy (97)
Layoffs (54)
Legal (1295)
Lung cancer (36)
Lymphoma (24)
Manufacturing (38)
Medical device (1370)
Medtech (1371)
Mergers & acquisitions (4314)
Metabolic disorders (71)
Neuroscience (426)
NextGen Class of 2024 (917)
Non-profit (706)
Northern California (366)
Obesity (40)
Opinion (32)
Parkinson's disease (34)
People (11264)
Phase I (5048)
Phase II (6709)
Phase III (5240)
Pipeline (122)
Postmarket research (438)
Preclinical (2110)
Radiopharmaceuticals (34)
Rare diseases (136)
Real estate (1032)
Regulatory (4786)
Research institute (841)
Southern California (261)
Startups (964)
United States (2912)
Vaccines (72)
Date
Today (26)
Last 7 days (175)
Last 30 days (625)
Last 365 days (8270)
2024 (8054)
2023 (9195)
2022 (13869)
2021 (13765)
2020 (11951)
2019 (8845)
2018 (6729)
2017 (7373)
2016 (6641)
2015 (8023)
2014 (5865)
2013 (4846)
2012 (4799)
2011 (4901)
2010 (4437)
Location
Africa (164)
Asia (23600)
Australia (2984)
California (757)
Canada (284)
China (106)
Colorado (22)
Connecticut (32)
Europe (21197)
Florida (61)
Illinois (28)
Indiana (58)
Japan (50)
Maryland (123)
Massachusetts (728)
Michigan (38)
Minnesota (26)
New Jersey (210)
New York (232)
North Carolina (157)
Northern California (366)
Ohio (30)
Pennsylvania (168)
South America (212)
Southern California (261)
Texas (81)
Utah (45)
Virginia (22)
Washington State (70)
139,558 Results for "touchlight genetics ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Curia expands biologics capabilities with access to Touchlight’s doggybone DNACuria collaborates with Touchlight to expand its mRNA manufacturing offering to enable access to enzymatic doggybone DNA (dbDNA™)
Curia, a leading contract research, development and manufacturing organization, and Touchlight, a company pioneering enzymatic DNA production, today announced an agreement which will provide Curia and its clients a streamlined means of access to Touchlight’s doggybone DNA (dbDNA).
July 24, 2023
·
2 min read
Touchlight’s enzymatic doggybone DNA used in the manufacture of Versameb’s VMB-100 for first-in-human clinical study
Touchlight announced that the Company has used its proprietary dbDNA as a critical starting material for manufacturing of VMB-100, a potency enhanced messenger ribonucleic acid encoding human insulin-like growth factor-1 to support Versameb’s first-in-human clinical study to treat chronic stress urinary incontinence.
November 21, 2023
·
4 min read
FDA
Touchlight Announces First FDA Clearance of an IND Utilising Doggybone DNA
Touchlight, a CDMO pioneering enzymatic DNA production to enable genetic medicines, today announced the first FDA clearance of an Investigational New Drug (IND) application in the US utilising doggybone DNA (dbDNA™).
February 28, 2023
·
2 min read
FDA Accepts Drug Master File, Signifying a New Milestone for Touchlight’s Enzymatic doggybone DNA Technology
Touchlight, a biotechnology company pioneering enzymatic DNA production to enable genetic medicines, today announced a ground-breaking new milestone for its enzymatic doggybone DNA (dbDNA™), following the FDA acceptance of the Drug Master File (DMF) for GMP grade dbDNA.
January 24, 2023
·
3 min read
Press Releases
WORK Medical Technology Group LTD’s Subsidiary, Hangzhou Shanyou, Showcases Products at MEDICA Trade Fair 2024
November 28, 2024
·
4 min read
Press Releases
AI/ML Innovations to Acquire Quantum Sciences Ltd
December 10, 2024
·
4 min read
Touchlight receives grant to advance rapid, scalable and thermostable doggybone DNA vaccine platform
Touchlight, a biotechnology company pioneering enzymatic DNA production to enable the genetic medicine revolution, is furthering pre-clinical development of its proprietary doggybone DNA vaccine platform, financed by a new grant received from the Bill & Melinda Gates Foundation.
November 28, 2022
·
2 min read
Press Releases
Hepion Pharmaceuticals, Inc. Announces Termination of Merger Agreement with Pharma Two B Ltd.
December 11, 2024
·
3 min read
Press Releases
Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer
November 18, 2024
·
7 min read
Touchlight and Odimma Therapeutics Announce Clinical Material Supply Agreement to Develop Personalised Cancer Therapy Utilising Doggybone DNA
Touchlight announces a development and supply agreement with Odimma Therapeutics, a French biotech company focusing on personalised cancer immunotherapy.
December 7, 2022
·
4 min read
1 of 13,956
Next
